Cargando…

Associations of cognitive impairment in patients with schizophrenia with genetic features and with schizophrenia-related structural and functional brain changes

Cognitive impairment is highly prevalent in patients with major psychiatric disorders (MPDs), including schizophrenia (SCZ), bipolar disorder, major depressive disorder, in whom it can be highly disruptive to community functioning and worsen prognosis. Previously, genetic factors and cognitive impai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuo, Chuanjun, Tian, Hongjun, Chen, Jiayue, Li, Qianchen, Yang, Lei, Zhang, Qiuyu, Chen, Guangdong, Cheng, Langlang, Zhou, Chunhua, Song, Xueqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437456/ https://www.ncbi.nlm.nih.gov/pubmed/36061201 http://dx.doi.org/10.3389/fgene.2022.880027

Ejemplares similares

Microglia and cognitive impairment in schizophrenia: translating scientific progress into novel therapeutic interventions
por: Zhuo, Chuanjun, et al.
Publicado: (2023)

Transcranial direct current stimulation of the occipital lobes with adjunct lithium attenuates the progression of cognitive impairment in patients with first episode schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Lithium produces bi-directionally regulation of mood disturbance, acts synergistically with anti-depressive/-manic agents, and did not deteriorate the cognitive impairment in murine model of bipolar disorder
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Baseline global brain structural and functional alterations at the time of symptom onset can predict subsequent cognitive deterioration in drug-naïve first-episode schizophrenia patients: Evidence from a follow-up study
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Lithium bidirectionally regulates depression- and mania-related brain functional alterations without worsening cognitive function in patients with bipolar disorder
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Acid sphingomyelinase/ceramide system in schizophrenia: implications for therapeutic intervention as a potential novel target
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Aberrant patterns of local and long-range functional connectivity densities in schizophrenia
por: Liu, Chuanxin, et al.
Publicado: (2017)

Metabolic risk factors of cognitive impairment in young women with major psychiatric disorder
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Risk-to-befit ratios of consecutive antidepressants for heavy menstrual bleeding in young women with bipolar disorder or major depressive disorder
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

In the era of whole-brain mapping for the exploration of mental disorders, we need to rethink our methods of rodent model establishment
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Testing the validity and reliability of the Chinese version of the Staden schizophrenia anxiety rating scale
por: Du, Chenyuan, et al.
Publicado: (2022)

A borderline personality assessment for adolescents: Validity and reliability of the Chinese languages borderline personality features scale (short form version) for adolescents/children
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Safety and Efficacy of High-Dose Vitamin B6 as an Adjunctive Treatment for Antipsychotic-Induced Hyperprolactinemia in Male Patients With Treatment-Resistant Schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2021)

Validity and reliability of a Chinese version of the self‐evaluation of negative symptoms
por: Chen, Guangdong, et al.
Publicado: (2023)

Prevalence of Heavy Menstrual Bleeding and Its Associated Cognitive Risks and Predictive Factors in Women With Severe Mental Disorders
por: Shan, Jianmin, et al.
Publicado: (2022)

Irreversible Primary Visual Cortex Impairment in a Mouse Model of High-Risk Schizophrenia
por: Chen, Xinying, et al.
Publicado: (2021)

Validation and reliability test of Chinese language patient-reported impact of symptoms in schizophrenia scale
por: Lin, Xiao, et al.
Publicado: (2023)

Low-dose lithium adjunct to atypical antipsychotic treatment nearly improved cognitive impairment, deteriorated the gray-matter volume, and decreased the interleukin-6 level in drug-naive patients with first schizophrenia symptoms: a follow-up pilot study
por: Zhuo, Chuanjun, et al.
Publicado: (2023)

Validation of a modified Chinese‐language version of the Davos Assessment of Cognitive Biases Scale (MCL‐DACOBS) in a sample of Chinese patients with schizophrenia
por: Chen, Guangdong, et al.
Publicado: (2023)

Double-Edged Sword of Tumour Suppressor Genes in Schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2019)

Brain structural and functional dissociated patterns in schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2017)

Strategies to solve the reverse inference fallacy in future MRI studies of schizophrenia: a review
por: Zhuo, Chuanjun, et al.
Publicado: (2020)

Lipidomics of the brain, retina, and biofluids: from the biological landscape to potential clinical application in schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2020)

Brain features of nearly drug‐naïve female monozygotic twins with first‐episode schizophrenia and the classification accuracy of brain feature patterns: A pilot study
por: Zhang, Tao, et al.
Publicado: (2020)

Metformin Enhances Antidepressant/Antipsychotic Combination Therapy of Schizophrenia With Comorbid Depression in a Murine Model
por: Zhou, Chunhua, et al.
Publicado: (2020)

Brain imaging features in schizophrenia with co‐occurring auditory verbal hallucinations and depressive symptoms—Implication for novel therapeutic strategies to alleviate the reciprocal deterioration
por: Zhuo, Chuanjun, et al.
Publicado: (2020)

Functional connectivity density alterations in schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2014)

NLRP3 Influences Cognitive Function in Schizophrenia in Han Chinese
por: Liu, Ruimei, et al.
Publicado: (2021)

Diffusion Tensor MR Imaging Evaluation of Callosal Abnormalities in Schizophrenia: A Meta-Analysis
por: Zhuo, Chuanjun, et al.
Publicado: (2016)

Mechanistic/mammalian target of rapamycin and side effects of antipsychotics: insights into mechanisms and implications for therapy
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Catatonic Schizophrenia: Cases with Possible Genetic Predisposition
por: Tariq, Maryam, et al.
Publicado: (2019)

Chromosomal Microarray Analysis as First-Tier Genetic Test for Schizophrenia
por: Chen, Chia-Hsiang, et al.
Publicado: (2021)

Adjunct ketamine treatment of depression in treatment‐resistant schizophrenia patients is unsatisfactory in pilot and secondary follow‐up studies
por: Zhuo, Chuanjun, et al.
Publicado: (2020)

Rethinking Schizophrenia and Depression Comorbidity as One Psychiatric Disorder Entity: Evidence From Mouse Model
por: Zhou, Chunhua, et al.
Publicado: (2020)

Polymorphisms in Dopaminergic Genes in Schizophrenia and Their Implications in Motor Deficits and Antipsychotic Treatment
por: Ye, Jiaen, et al.
Publicado: (2019)

The genetic basis of onset age in schizophrenia: evidence and models
por: Zhan, Na, et al.
Publicado: (2023)

Lower risk of liver cancer in patients with schizophrenia: a systematic review and meta-analysis of cohort studies
por: Xu, Dali, et al.
Publicado: (2017)

A Perspective of the Cross-Tissue Interplay of Genetics, Epigenetics, and Transcriptomics, and Their Relation to Brain Based Phenotypes in Schizophrenia
por: Liu, Jingyu, et al.
Publicado: (2018)

Genetic Effects of the Schizophrenia-Related Gene DTNBP1 in Temporal Lobe Epilepsy
por: Tao, Hua, et al.
Publicado: (2021)

Validity and reliability of a Chinese language suicide screening questionnaire-observer rating (CL-SSQ-OR) assessment for children/adolescents
por: Yu, Haiping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a6ju5aopo3chauocg7an923til